Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition

Targeting the early steps of the glycolysis pathway in cancers is a well-established therapeutic strategy; however, the doses required to elicit a therapeutic effect on the cancer can be toxic to the patient. Consequently, numerous preclinical and clinical studies have combined glycolytic blockade w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Wilson, John J., Chow, Kin-hoe, Labrie, Nathan J., Branca, Jane A., Sproule, Thomas J., Perkins, Bryant R. A., Wolf, Elise E., Costa, Mauro, Stafford, Grace, Rosales, Christine, Mills, Kevin D., Roopenian, Derry C., Hasham, Muneer G.
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343731/
https://ncbi.nlm.nih.gov/pubmed/30183475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1507666
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares